BackRevance Therapeutics Overview

Revance Therapeutics Profit Margin

Profitability ratio analysis for RVNC.

Quarterly Profit Margin

-58.64%
↑ 76.42% YoY

As of Sep 2024

Annual Profit Margin (TTM)

-73.46%
↑ 62.46% YoY

Trailing 12 months ending Sep 2024

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin